mHealth Asia-Pacific Market - Opportunities and Forecasts, 2014 - 2020
- ALL563770
- 122 Pages
- March 2016
- Medical Devices
Asia Pacific mHealth market projects a remarkable growth rate, supplemented with the growing awareness of mHealth devices and services that aid in improve the quality of life for patients stricken with lifestyle diseases. The growing prevalence of lifestyle diseases such as diabetes, obesity, hypertension, chronic obstructive pulmonary disease (COPD) and obstructive sleep apnea (OSA), in Asia Pacific region, creates an impending need of technologically advanced platforms for the prevention and treatment of these diseases. According to the National Institute of Health, China and India are the two highest populated nations, with an approximate diabetes count of 150 million patients. Thus, the need for regular health monitoring and treatment would be addressed by launch of smartphone-based medical devices.
The Asia Pacific mHealth market was evaluated at $2.3 billion in 2014, and is expected to register a CAGR of 35.8% during the forecast period (2015 to 2020). This growth is primarily driven by active government initiatives and the rising adoption of smartphones in Asia-pacific region. Presently, the market is witnessing a resurgence due to the increasing disposable incomes and the growing adoption of mobile phones. Moreover, a similar trend is observed in developing countries like India and Indonesia. However, factors such as consumers affordability, access to healthcare services and inaccuracy in results arising from discrepancies in devices would limit the growth of the market.
Themarket is segmented into devices, services, application, stakeholders and geography. Based on device type, the market is segmented into blood glucose meters, BP monitors, pulse oximetry, neurological monitoring devices, apnea and sleep monitors, wearable fitness sensor device & heart rate meters and others. The BP monitors segment holds a dominant share; however, the blood glucose meters segment is estimated to register the fastest growth in the Asia Pacific mHealth devices market. Factors such as incidences of hypertension, sedentary lifestyles, the increasing count of diabetics, supplement the adoption of mHealth devices. Based on services, the market is segmented into diagnosis services, monitoring services, prevention, treatment and wellness & healthcare system strengthening solutions. The monitoring services segment holds a dominant share in the Asia Pacific mHealth services market and would register the highest CAGR throughout the forecast period (2015-2020). Based on stake holders, the market is segmented into mobile operators, device vendors, healthcare providers and application players. Within the segment of stakeholders, mobile operators occupy a dominant share in themarket. The segment of mobile application developers would register the highest CAGR during the forecast period (2015-2020). Based on applications, the industry is segmented into cardiovascular diseases, diabetes, respiratory diseases, neurological diseases and others. The cardiovascular diseases segment holds a dominant share in the Asia Pacific mHealth applications market; however, the diabetes application segment is expected to register the highest CAGR during the forecast period (2015-2020). Based on country, the market is segmented across Australia, China, Japan, India and Rest of Asia Pacific. China accounts for the largest market share, whilst India is the fastest growing region in thismarket.
The key players profiled in this report include - Philips Healthcare, Omron HealthCare, Inc., Bayer Healthcare, LifeWatch AG, Masimo Corporation, Sanofi S.A., Boston Scientific Corporation, AT&T Inc. and Johnson & Johnson.
KEY BENEFITS
- The report covers a detailed quantitative analysis of the current market and estimations through 2014-2020, which would enable the stakeholders to capitalize on prevailing market opportunities
- Themarket scenario is comprehensively analyzed based on key countries
- Key market players are profiled in the report and their strategies are analyzed thoroughly, which helps in understanding the competitive outlook of the market
- Extensive analysis of the market is conducted by closely following key product positioning and monitoring the top contenders within the market framework
- Comprehensive analysis of factors that drive and restrict the growth of themarket, is provided in the report
- Exhaustive analysis of themarket, by device type, helps in understanding the types of devices that are currently being used along with the variants that would gain prominence in future
ASIA PACIFIC mHEALTH MARKET KEY SEGMENTS:
By Devices
- Blood glucose meters
- BP monitors
- Pulse oximetry
- Neurological monitoring devices
- Apnea and sleep monitors
- Wearable fitness sensor device & heart rate meters
- Others
By Services
- Diagnosis services
- Monitoring services
- Prevention
- Treatment
- Wellness and healthcare system strengthening solutions
By Stakeholders
- Mobile operators
- Device vendors
- Healthcare providers
- Application players
By Application
- Cardiovascular diseases
- Diabetes
- Respiratory diseases
- Neurological diseases
- Others
By Country
- Australia
- China
- Japan
- India
- Rest of Asia-Pacific
CHAPTER 1 INTRODUCTION
1.1 Report description
1.2 Key benefits
1.3 Market segmentation
1.4 Research methodology
1.4.1 Secondary research
1.4.2 Primary research
1.4.3 Analyst tools and models
CHAPTER 2 EXECUTIVE SUMMARY
2.1 CXO perspective
CHAPTER 3 MARKET OVERVIEW
3.1 Market definition and scope
3.2 Key findings
3.2.1 Top impacting factors
3.2.2 Top investment pockets
3.3 Porters five forces analysis
3.3.1 Bargaining power of buyers
3.3.2 Bargaining power of supplier
3.3.3 Threat of new entrant
3.3.4 Threat of substitute
3.3.5 Intensity of rivalry
3.4 Value chain analysis
3.4.1 Primary activities
3.4.2 Secondary activities
3.5 Market dynamics
3.5.1 Drivers
3.5.1.1 Integration of wireless technologies with portable healthcare devices
3.5.1.2 Increase in incidences of lifestyle diseaseS
3.5.1.3 Cost and convenience Factors
3.5.1.4 Technological integration
3.5.1.5 increasing government initiatives
3.5.1.6 Affordability of smartphones
3.5.2 Restraints
3.5.2.1 Lower adoption accross developing economies
3.5.2.2 Weak reimbursement coverage
3.5.2.3 Technological awareness among the ageing population
3.5.3 Opportunities
3.5.3.1 Untapped market of developing economies
3.5.3.2 Rising Opportunities in the form of bundled services
CHAPTER 4 BY DEVICES
4.1 Blood glucose meter
4.1.1 Key Market Trends
4.1.2 Key Growth Factors and Opportunity
4.1.3 Market Size and Forecast
4.2 BP monitors
4.2.1 Key Market Trends
4.2.2 Key growth factors and opportunities
4.2.3 Market size and forecast
4.3 Pulse oximetry
4.3.1 Key market trends
4.3.2 Key growth factors and opportunity
4.3.3 Market size and forecast
4.4 Neurological monitoring
4.4.1 Key market trends
4.4.2 Key growth factors and opportunity
4.4.3 Market size and forecast
4.5 Cardiac monitors
4.5.1 Key market trends
4.5.2 Key growth factors and opportunity
4.5.3 Market size and forecast
4.6 Apnea sleep monitors
4.6.1 Key market trends
4.6.2 Key growth factors and opportunity
4.6.3 Market size and forecast
4.7 Wearable fitness sensor device and heart rate meters
4.7.1 Key market trends
4.7.2 Key growth factors and opportunity
4.7.3 Market size and forecast
4.8 Others
4.8.1 Market Size and Forecast
CHAPTER 5 BY SERVICES
5.1 Prevention
5.1.1 Market size and forecast
5.2 Diagnostic services
5.2.1 Market size and forecast
5.3 Monitoring services
5.3.1 Market size and forecast
5.4 Treatment
5.4.1 Market size and forecast
5.5 Wellness and healthcare system strengthening solutions
5.5.1 Market size and forecast
CHAPTER 6 BY STAKEHOLDERS
6.1 Mobile operators
6.1.1 Market size and forecast
6.2 Device vendors
6.2.1 Market Size and Forecast
6.3 Healthcare providers
6.3.1 Market size and forecast
6.4 Application/ content players
6.4.1 Market size and forecast
CHAPTER 7 BY APPLICATION
7.1 Cardiovascular
7.1.1 Market size and forecast
7.2 Diabetes
7.2.1 Market size and forecast
7.3 Respiratory
7.3.1 Market size and forecast
7.4 Neurology
7.4.1 Market size and forecast
7.5 Others
7.5.1 Market size and forecast
CHAPTER 8 BY COUNTRY
8.1 Overview
8.1.1 Key market trends
8.1.2 Key growth factors and opportunities
8.1.3 Market size and forecast
8.2 Australia
8.2.1 Market Size and Forecast
8.3 China
8.3.1 Market Size and Forecast
8.4 Japan
8.4.1 Market Size and Forecast
8.5 India
8.5.1 Market Size and Forecast
8.6 Rest of Asia-Pacific
8.6.1 Market Size and Forecast
CHAPTER 9 COMPANY PROFILS
9.1 LifeWatch AG
9.1.1 Company overview
9.1.2 LifeWatch AG snapshot
9.1.3 Operating business segment overview
9.1.4 Business performance
9.1.5 Strategic moves and development
9.1.6 SWOT analysis of LifeWatch AG
9.2 Masimo Corporation
9.2.1 Company overview
9.2.2 Masimo Corporation snapshot
9.2.3 Operating business segment overview
9.2.4 Business performance
9.2.5 Strategic moves and developments
9.2.6 SWOT analysis of Masimo Corporation
9.3 Omron healthcare Inc.
9.3.1 Company overview
9.3.2 Omron Healthcare Snapshot
9.3.3 Operating business segment overview
9.3.4 Business performance
9.3.5 Strategic moves and developments
9.3.6 SWOT analysis of Omron Healthcare Inc.
9.4 Philips healthcare (a division of Royal Philips company)
9.4.1 Company overview
9.4.2 Philips Healthcare snapshot
9.4.3 Operating business segment overview
9.4.4 Business performance
9.4.5 Strategic moves and developments
9.4.6 SWOT analysis of Philips Healthcare
9.5 Bayer Healthcare (a division of Bayer)
9.5.1 Company overview
9.5.2 Bayer Healthcare snapshot
9.5.3 Operating business segment overview
9.5.4 Business performance
9.5.5 Strategic moves and development
9.5.6 SWOT analysis Of Bayer Healthcare
9.6 Sanofi
9.6.1 Company overview
9.6.2 Sanofi snapshot
9.6.3 Operating business segment overview
9.6.4 Business performance
9.6.5 Strategic moves and developments
9.6.6 SWOT analysis of Sanofi
9.7 Boston Scientific Corporation
9.7.1 Company overview
9.7.2 Boston Scientific Corporation snapshot
9.7.3 Operating business segment
9.7.4 Business performance
9.7.5 Strategic moves and developments
9.7.6 SWOT analysis of Boston Scientific Corporation
9.8 AT&T Inc.
9.8.1 Company overview
9.8.2 AT&T Inc. snapshot
9.8.3 Operating business segment
9.8.4 Business performance
9.8.5 Strategic moves and developments
9.8.6 SWOT analysis of AT&T Inc.
9.9 Johnson & Johnson
9.9.1 Company overview
9.9.2 Johnson & Johnson Inc snapshot
9.9.3 Operating business segment overview
9.9.4 Business performance
9.9.5 Strategic moves and developments
9.9.6 SWOT analysis of Johnson & Johnson.
List of Figures
FIG. 1 TOP FACTORS IMPACTING ASIA-PACIFIC MHEALTH MARKET (2014-2020)
FIG. 2 TOP INVESTMENT POCKETS IN ASIA-PACIFIC MHEALTH MARKET (2014-2020)
FIG. 3 PORTERS FIVE FORCES ANALYSIS
FIG. 4 VALUE CHAIN ANALYSIS OF ASIA-PACIFIC MHEALTH MARKET
FIG. 5 PENETRATION OF SMARTPHONE USERS
FIG. 6 COST AND MANUFACTURERS OF HEART RATE MONITORS
FIG. 7 MORTALITY INCIDENCES OF CVD (2010-2030)
FIG. 8 ASTHMA PREVALENCE IN UNITED STATES IN 2011
FIG. 9 BUSINESS PERFORMANCE OF LIFEWATCH 2012-2014 ($MILLION)
FIG. 10 REVENUE BY REGION (2014)
FIG. 11 SWOT ANALYSIS OF LIFEWATCH AG
FIG. 12 BUSINESS PERFORMANCE OF MASIMO CORPORATION 2012-2014 ($MILLION)
FIG. 13 SWOT ANALYSIS OF MASIMO CORPORATION
FIG. 14 NET SALES OF OMRON HEALHCARE ($MILLION)
FIG. 15 NET SALES OF OMRON HEALTHCARE OPERATING SEGMENT (2013)
FIG. 16 NET SALES OF OMRON HEALTHCARE BY REGION (2013)
FIG. 17 SWOT ANALYSIS OF OMRON HEALTHCARE INC.
FIG. 18 PHILIPS HEALTHCARE NET SALES 2012-2014 ($MILLION)
FIG. 19 PHILIPS HEALTHCARE REVENUE BY OPERATING SEGMENT (2014)
FIG. 20 SWOT ANALYSIS OF PHILIPS HEALTHCARE
FIG. 21 NET SALES OF BAYER HEALTHCARE 2012-2014 ($MILLION)
FIG. 22 BAYER HEALTHCARES REVENUE BY OPERATING SEGMENT IN 2014
FIG. 23 SWOT ANALYSIS OF BAYER HEALTHCARE
FIG. 24 NET SALES OF SANOFI 2012-2014 ($MILLION)
FIG. 25 NET SALES OF SANOFI BY OPERATING SEGMENT (2014)
FIG. 26 NET SALES OF SANOFI BY GEOGRAPHY 2014
FIG. 27 SWOT ANALYSIS OF SANOFI
FIG. 28 OPERATIONAL SALES OF BOSTON SCIENTIFIC 2012-2014 ($MILLION)
FIG. 29 OPERATIONAL SALES BY OPERATING SEGMENT 2014
FIG. 30 SWOT ANALYSIS OF BOSTON SCIENTIFIC CORPORATION
FIG. 31 REVENUE OF AT&T INC. 2012-2014 ($MILLION)
FIG. 32 SWOT ANALYSIS OF AT&T INC.
FIG. 33 NET SALES OF JOHNSON & JOHNSON 2012-2014 ($MILLION)
FIG. 34 NET SALES BY OPERATING SEGMENT 2014
FIG. 35 SWOT ANALYSIS OF JOHNSON & JOHNSON.
List of Tables
TABLE 1 GOVERNMENT OF INDIA MHEALTH INITIATIVES
TABLE 2 ASIA-PACIFIC MHEALTH MARKET, BY DEVICES, 2014-2020 ($MILLION)
TABLE 3 ASIA-PACIFIC MHEALTH MARKET, BY COUNTRY, 2014-2020, ($MILLION)
TABLE 4 ASIA-PACIFIC MHEALTH BLOOD GLUCOSE METERS MARKET, BY COUNTRY, 2014-2020, ($MILLION)
TABLE 5 MOBILE COMPATIBLE BP MONITORS
TABLE 6 ASIA-PACIFIC BP MONITORS MARKET, BY COUNTRY, 2014-2020, ($MILLION)
TABLE 7 AVAILABLE PULSE OXIMETERS AND ITS COST
TABLE 8 ASIA-PACIFIC PULSE OXIMETRY MARKET, BY COUNTRY, 2014-2020, ($MILLION)
TABLE 9 ESTIMATED PEOPLE WITH DEMENTIA IN ASIA-PACIFIC REGION
TABLE 10 ASIA-PACIFIC MHEALTH NEUROLOGICAL DEVICES MARKET, BY COUNTRY, 2014-2020 ($MILLION)
TABLE 11 ASIA-PACIFIC MHEALTH CARDIAC MONITORS MARKET, BY COUNTRY, 2014-2020 ($MILLION)
TABLE 12 SLEEP APNEA DEVICES
TABLE 13 ASIA-PACIFIC MHEALTH APNEA SLEEP MONITORS MARKET, BY COUNTRY, 2014-2020 ($MILLION)
TABLE 14 WEARABLE FITNESS DEVICES AND ITS COST
TABLE 15 ASIA-PACIFIC WEARABLE FITNESS SENSORS DEVICES AND HEART RATE METERS MARKET, BY COUNTRY, 2014-2020 ($MILLION)
TABLE 16 ASIA-PACIFIC MHEALTH OTHER DEVICES MARKET, BY COUNTRY, 2014-2020 ($MILLION)
TABLE 17 ASIA-PACIFIC MHEALTH SERVICES MARKET, BY TYPE, 2014-2020 ($MILLION)
TABLE 18 ASIA-PACIFIC MHEALTH SERVICES MARKET, BY COUNTRY,, 2014-2020 ($MILLION)
TABLE 19 SMARTPHONE APPS FOR PREVENTIVE SERVICES
TABLE 20 MOBILE HEALTHCARE SOLUTION PROVIDED BY CDAC
TABLE 21 ASIA-PACIFIC MHEALTH PREVENTION SERVICE MARKET, BY COUNTRY, 2014 2020 ($MILLION)
TABLE 22 ASIA-PACIFIC MHEALTH DIAGNOSIS SERVICE MARKET, BY COUNTRY, 2014 2020 ($MILLION)
TABLE 23 ASIA-PACIFIC MHEALTH MONITORING SERVICE MARKET, BY COUNTRY, 2014 2020 ($MILLION)
TABLE 24 ASIA-PACIFIC MHEALTH TREATMENT SERVICE MARKET, BY COUNTRY, 2014 2020 ($MILLION)
TABLE 25 ASIA-PACIFIC MHEALTH WELLNESS AND HEALTHCARE SYSTEMS STRENGTHENING SOLUTIONS MARKET, BY COUNTRY, 2014 2020 ($MILLION)
TABLE 26 ASIA-PACIFIC MHEALTH MARKET, BY STAKEHOLDERS,2014 2020 ($MILLION)
TABLE 27 ASIA-PACIFIC MHEALTH STAKEHOLDERS MARKET, BY COUNTRY, 2014-2020 ($MILLION)
TABLE 28 ASIA-PACIFIC MHEALTH MOBILE OPERATORS MARKET, BY COUNTRY, 2014-2020, ($MILLION)
TABLE 29 ASIA-PACIFIC MHEALTH DEVICE VENDORS MARKET, BY COUNTRY, 2014-2020, ($MILLION)
TABLE 30 ASIA-PACIFIC MHEALTH HEALTHCARE PROVIDERS MARKET, BY COUNTRY, 2014-2020, ($MILLION)
TABLE 31 ASIA-PACIFIC MHEALTH APPLICATION/CONTENT PLAYERS MARKET, BY COUNTRY, 2014-2020, ($MILLION)
TABLE 32 ASIA-PACIFIC MHEALTH MARKET BY APPLICATION, 2014 2020 ($MILLION)
TABLE 33 ASIA-PACIFIC MHEALTH APPLICATION MARKET BY COUNTERY, 2014-2020, ($MILLION)
TABLE 34 ASIA-PACIFIC MHEALTH CARDIOVASCULAR APPLICATION MARKET, BY GEOGRAPHY, 2014-2020, ($MILLION)
TABLE 35 PREVALENCE AND PROJECTIONS OF DIABETES IN ASIA-PACIFIC REGION
TABLE 36 ASIA-PACIFIC MHEALTH DIABETES APPLICATION MARKET, BY GEOGRAPHY, 2014-2020, ($MILLION)
TABLE 37 ASIA-PACIFIC MHEALTH RESPIRATORY APPLICATION MARKET, BY COUNTRY, 2014-2020, ($MILLION)
TABLE 38 ASIA-PACIFIC NUMBER OF DALYS FOR NEUROLOGICAL DISORDERS PROJECTION FOR 2015 AND 2030
TABLE 39 ASIA-PACIFIC MHEALTH NEUROLOGY APPLICATION MARKET, BY COUNTRY, 2014-2020, ($MILLION)
TABLE 40 ASIA-PACIFIC MHEALTH OTHER APPLICATIONS MARKET, BY COUNTRY, 2014-2020 ($MILLION)
TABLE 41 IMPACT ANALYSIS PENETRATING TO ASIA-PACIFIC COUNTRIES 2014
TABLE 42 ASIA-PACIFIC MHEALTH MARKET, BY COUNTRY, 2014-2020 ($MILLION)
TABLE 43 AUSTRALIA MHEALTH (DEVICES AND SERVICES) MARKET, 2014-2020, ($MILLION)
TABLE 44 CHINA MHEALTH (DEVICES AND SERVICES) MARKET, 2014-2020, ($MILLION)
TABLE 45 JAPAN MHEALTH (DEVICES AND SERVICES)MARKET, 2014-2020, ($MILLION)
TABLE 46 INDIA MHEALTH (DEVICES AND SERVICES)MARKET, 2014-2020, ($MILLION)
TABLE 47 REST OF ASIA-PACIFIC MHEALTH (DEVICES AND SERVICES) MARKET, 2014-2020, ($MILLION)
TABLE 48 LIFEWATCH AG COMPANY SNAPSHOT
TABLE 49 OPERATING BUSINESS SEGMENT OVERVIEW
TABLE 50 MASIMO CORPORATION SNAPSHOT
TABLE 51 OPERATING BUSINESS SEGMENT OVERVIEW
TABLE 52 OMRON HEALTHCARE SNAPSHOT
TABLE 53 OPERATING BUSINESS SEGMENT OVERVIEW
TABLE 54 PHILIPS HEALTHCARE SNAPSHOT
TABLE 55 OPERATING BUSINESS SEGMENT OVERVIEW
TABLE 56 BAYER HEALTHCARE SNAPSHOT
TABLE 57 OPERATING BUSINESS SEGMENT OVERVIEW
TABLE 58 SANOFI SNAPSHOT
TABLE 59 OPERATING BUSINESS SEGMENTS OVERVIEW
TABLE 60 BOSTON SCIENTIFIC CORPORATION SNAPSHOT
TABLE 61 OPERATING BUSINESS SEGMENT OVERVIEW
TABLE 62 AT&T INC. SNAPSHOT
TABLE 63 OPERATING BUSIMESS SEGMENT OVERVIEW
TABLE 64 JOHNSON & JOHNSON INC SNAPSHOT
TABLE 65 OPERATING BUSINESS SEGMENT OVERVIEW
Similar Reports
Medical implants are permanent devices such as pacemakers or temporary devices such as fracture plates which are removed once their function is completed. These implants are made up of bone, tissue, skin, ceramics, metals, plastics, and other natural materials...
- Publish Date: August 21, 2016
- $5370
Ostomy is a surgery wherein an artificial opening, known as stoma, is created from the colon in the human body to eliminate body wastes such as urine, mucus, and stools, which are collected in artificial bags called ostomy drainage bags. These plastic/rub...
- Publish Date: December 1, 2016
- $5370
Laparoscopy is a minimally invasive procedure used to examine organs inside the abdomen or pelvic cavities by inserting a laparoscope through a small incision in the abdomen. A laparoscope comprises a long, thin tube with high-intensity light, and high-re...
- Publish Date: April 24, 2017
- $5370
